SGLT-2 Inhibitors for Cardiovascular Outcomes in Heart Failure With Preserved Ejection Fraction
SGLT-2 Inhibitors for Cardiovascular Outcomes in Heart Failure With Preserved Ejection Fraction
About this item
Full title
SGLT-2 Inhibitors for Cardiovascular Outcomes in Heart Failure With Preserved Ejection Fraction
Author / Creator
Publisher
United States: American Academy of Family Physicians
Journal title
American family physician, 2023, Vol.107 (1), p.81-82
Language
English
Formats
Publication information
Publisher
United States: American Academy of Family Physicians
Subjects
More information
Scope and Contents
Contents
Do sodium-glucose cotransporter-2 (SGLT-2) inhibitors improve cardiovascular outcomes in patients who have heart failure with preserved ejection fraction (HFpEF)?
Alternative Titles
Full title
SGLT-2 Inhibitors for Cardiovascular Outcomes in Heart Failure With Preserved Ejection Fraction
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2769374465
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2769374465
Other Identifiers
ISSN
0002-838X
E-ISSN
1532-0650
